Results 111 to 120 of about 27,935 (169)

Low Levels of Clinically Significant Drug Resistance Mutations to Dolutegravir Among Children Living with HIV Failing on First-Line Antiretroviral Therapy in Uganda. [PDF]

J Acquir Immune Defic Syndr
Magongo EN, Hast M, Nabitaka V, Nakanwagi M, Twinomujjuni E, Dowling S, Senyama G, Nzano B, Alwano M, Nakaweesi J, Nazziwa E, Namayanja G, Nkolo E, Ayitewala A, Hackett S.   +14 more
europepmc   +1 more source

Pure red cell aplasia post-SARS-CoV-2 infection: a case report in an HIV-positive patient. [PDF]

Front Med (Lausanne)
Wang Y, Tang S, Bian R, Wen Y.
europepmc   +1 more source

Demographic and Socioeconomic Factors Associated With ART Nonadherence Among 15 Years and Older South Africans. Evidence From the 2022 Cross-Sectional Population-Based Household Survey. [PDF]

AIDS Res Treat
Chamane S, Mabaso M, Reddy T, Chambale P, Skhosana K, Sewpaul R, Makola L, Ngcobo A, Mehlomakulu V, Molopa L, Jooste S, Moyo S, Zungu N, Zuma K.   +13 more
europepmc   +1 more source

Efficacy and safety of switching from lopinavir/ritonavir-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV: A multicenter retrospective study. [PDF]

Virol Sin
Fu J, Guo Y, Zheng G, Yang Z, Shi J, Yan D, Yu J, Sun L, Zhao H.   +8 more
europepmc   +1 more source

Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs. [PDF]

Biomacromolecules
Starenko D, Kostka L, Behalova K, Kotrchova L, Subr V, Kovarova J, Roubalova R, Sirova M, Etrych T, Kovar M.   +9 more
europepmc   +1 more source

Insights into Antiviral Candidates against Oropouche Virus: A Molecular Dynamics Study. [PDF]

ACS Phys Chem Au
Colherinhas G, Cardoso WB.
europepmc   +1 more source

Drug-Target Interaction Prediction via Dual-Interaction Fusion. [PDF]

Molecules
Li X, Li Z, Wei B, Zeng Y.
europepmc   +1 more source

Pharmacokinetics of dexamethasone in tuberculosis meningitis

Calderin JM, Resendiz-Galvan JE, Abdelgawad N, Davis A, Stek C, Wiesner L, Meintjes G, Wilkinson RJ, Denti P, Wasserman S.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Kaletra (Lopinavir/Ritonavir)

Annals of Pharmacotherapy, 2002
OBJECTIVE: To review the pharmacology, virology, pharmacokinetics, efficacy, safety, and clinical use of lopinavir/ritonavir (Kaletra, Abbott Laboratories). DATA SOURCES: English-language MEDLINE and AIDSline searches were performed ...
Angela Kashuba
exaly   +3 more sources

Lopinavir

Reactions Weekly, 2006
openaire   +2 more sources